Allegro Nv/sa
Clinical trials sponsored by Allegro Nv/sa, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New gel injection could ease arthritic knees Results expected Oct 2026 (estimated)
-
New gel injection could ease arthritic knees
Symptom relief OngoingThis study tests a single injection of Hydrogel OA 2% in 20 adults with knee osteoarthritis. The goal is to see if the gel is safe and tolerable over 13 weeks to 12 months. Participants must be 35–75 years old with a BMI between 20 and 35.
Sponsor: Allegro NV/SA • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Knee gel injection trial pulled before it began
Symptom relief CancelledThis study was designed to test whether a new gel called Hydrogel OA 2% could safely relieve knee osteoarthritis pain better than a standard treatment. It planned to enroll adults with knee OA and give them one injection, then track side effects and symptom improvement for 26 wee…
Sponsor: Allegro NV/SA • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC